Advertisement
News and applications for life science research professionals
Subscribe to Bioscience Technology All
View Sample

FREE Email Newsletter Bioscience Technology Daily

Drug Candidate Blocks 'Chili-pepper Receptor'

August 20, 2014 11:53 am | News | Comments

 As anyone who has bitten into a chili pepper knows, its burning spiciness— though irresistible to some — is intolerable to others. Scientists exploring the chili pepper’s effect are using their findings to develop a new drug candidate for many kinds of pain.

TOPICS:

3-D-printed Organs for Transplant One Step Closer

August 20, 2014 11:43 am | News | Comments

Printing whole new organs for transplants sounds like something out of a sci-fi movie, but the real-life budding technology could one day make actual kidneys, livers, hearts and other organs for patients who desperately need them.     

TOPICS:

Liberian security forces seal slum to halt Ebola

August 20, 2014 5:21 am | by The Associated Press | News | Comments

Security forces are enforcing a quarantine around a slum in the Liberian capital, where looters raided an Ebola screening center over the weekend and removed contaminated sheets and other items. Liberian President Ellen Johnson Sirleaf also imposed a nighttime curfew, saying that authorities have...

Advertisement

Liberia president declares Ebola curfew

August 19, 2014 8:21 pm | by Jonathan Paye-layleh - Associated Press - Associated Press | News | Comments

Liberia's president declared a curfew and ordered security forces to quarantine a slum home to at least 50,000 people late Tuesday as the West African country battled to stop the spread of Ebola in the capital. The measures came as authorities said that three health workers in the country who...

FDA approves new drug for rare genetic disease

August 19, 2014 6:20 pm | by The Associated Press | News | Comments

The Food and Drug Administration has approved a new capsule-based drug to treat Gaucher's disease. Regulators approved the new drug, Cerdelga, for patients with the Type 1 form of the rare genetic disorder, which causes excess fat to build up in the spleen, liver and bone marrow. Cerdelga is...

Livestrong $50M gift biggest since Armstrong exit

August 19, 2014 3:22 pm | by Paul J. Weber - Associated Press - Associated Press | News | Comments

Lance Armstrong's former charity made the largest investment in its history Tuesday by giving $50 million to the University of Texas, marking the group's biggest splash since severing ties with the disgraced cyclist as it pushes to restore momentum and influence after a tumultuous two years. The...

Remote-Controlled, Battery-Powered Flow Meter

August 19, 2014 2:27 pm | Product Releases | Comments

The new version of the 800 Series Turbine Flow Meter from Titan Enterprises is for companies who wish to monitor flow without installing a wiring loom or in remote situations.

Serial Dilution in 96-, 384-well Microplates

August 19, 2014 2:00 pm | Product Releases | Comments

Integra’s Row Dilution Plate Holder accessory for the VIAFLO 96 and 384 handheld benchtop pipettes adds the functionality to perform serial dilutions in rows. Serial dilutions are often carried out in row format because it allows experimenters to dilute more samples.

TOPICS:
Advertisement

Physical Fitness Makes Kids' Brains Bigger

August 19, 2014 1:41 pm | News | Comments

A new study of 9- and 10-year-olds finds that those who are more aerobically fit have more fibrous and compact white-matter tracts in the brain than their peers who are less fit.                     

TOPICS:

Targeted Brain Stimulation Aids Stroke Recovery

August 19, 2014 1:27 pm | News | Comments

When investigators applied light-driven stimulation to nerve cells in the brains of mice that had suffered strokes several days earlier, the mice showed significantly greater recovery in motor ability than mice that had experienced strokes but whose brains weren’t stimulated.

TOPICS:

AstraZeneca says DOJ closes probe into drug trial

August 19, 2014 1:21 pm | by The Associated Press | News | Comments

British drugmaker AstraZeneca says the U.S. Department of Justice has closed its investigation into a clinical trial of the company's blood thinner Brilinta, and plans no further action. The company announced in October 2013 that federal officials were looking into the 18,000-patient study, which...

DNA Sequencing Spots Genetic Key to Lupus

August 19, 2014 12:30 pm | News | Comments

Medical researchers have used DNA sequencing to identify a gene variant responsible for causing lupus in a young patient. The development shows that, for the first time, it is feasible for researchers to identify the individual causes of lupus in patients by using DNA sequencing.

TOPICS:

Engineering New Bone Growth

August 19, 2014 12:07 pm | News | Comments

Chemical engineers have devised a new implantable tissue scaffold coated with bone growth factors that are released slowly over a few weeks. When applied to bone injuries or defects, the scaffold induces the body to rapidly form new bone that looks and behaves just like the original tissue.

TOPICS:

Breakthrough in the Fight Against Drug-resistant Superbugs

August 19, 2014 11:51 am | News | Comments

Scientists have made a breakthrough in the fight against the most resistant hospital superbugs by developing the first innovative antibacterial gel that acts to kill Pseudomonas aeruginosa, staphylococci and E. coli, using natural proteins.     

TOPICS:

Reactivated Gene Sets Immune System Back 500M Years

August 19, 2014 11:37 am | News | Comments

A single factor can reset the immune system of mice to a state likely similar to what it was 500 million years ago. Scientists reactivated expression of an ancient gene in mice, which is not normally expressed in the mammalian immune system, and found that the animals developed a fish-like thymus.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading